Abstract
There is increasing evidence1 that the sudden, unpredictable event initiating myocardial infarction is Assuring of an atherosclerotic plaque. The resulting haemorrhage into the arterial wall produces obstructive platelet thrombi, just as arterial haemorrhages elsewhere produce haemostatic platelet plugs. It has been suggested1 that such platelet aggregation depends on ADP originating in red cells which are subjected to excessive haemodynamic stress at the site of haemorrhage. The release of ADP from red cells has been demonstrated in vitro in equivalent conditions of shear stress2,3; and other mechanisms, such as activation by collagen, cannot account for the rapidity with which the platelets react4. One of us (G.V.R.B.) has suggested that drugs capable of counteracting haemolysis5 might diminish the activating effect of erythrocytes on platelets6 and so inhibit their aggregation as thrombi. Thus, chlorpromazine, added to human blood at concentrations which diminish haemolysis but do not directly affect platelet aggregation7,8, prolonged the ‘bleeding time’ from small holes in artificial vessels where extravasation is terminated, as in living arterioles, by aggregated platelets9. The bleeding time was also prolonged by apyrase, consistent with the conclusion that the chlorpromazine acted through decreasing plasma ADP. We show here that this occurs through the anti-haemolytic action of chlorpromazine.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Born, G. V. R. Arterial Thrombosis and its Prevention (Excerpta Medica, Amsterdam, in the press).
Schmid-Schönbein, H. et al. Biorrheology (in the press).
Schmid-Schönbein, H., Rieger, H. & Fischer, T. Blood Vessels: Problems Arising at the Borders of Natural and Artificial Blood Vessels (eds Effert, S. & Meyer-Erkelenz, J. D.) 57–63 (Springer, Berlin, 1977).
Born, G. V. R. Br. med. Bull. 33, 193–197 (1977).
Seaman, P. Pharmac. Rev. 24, 583–655 (1972).
Gaarder, A., Jonsen, J., Laland, S., Hellem, A. & Owren, P. Nature 192, 531–533 (1961).
Ahtee, L. & Paasonen, M. K. J. Pharm. Pharmac. 18, 126–128 (1966).
Mills, D. C. B. & Roberts, G. C. K. Nature 213, 35–38 (1967).
Born, G. V. R., Bergqvist, D. & Afors, K.-E. Nature 259, 233–236 (1976).
Born, G. V. R. Nature 194, 927–929 (1962).
Haslam, R. J. & Mills, D. C. B. Biochem. J. 103, 773–784 (1967).
Milton, J. C., Yung, W., Glushak, C. & Frojmovic, M. M. Can. J. Physiol. Pharmac. (in the press).
Schmid-Schönbein, H. Handbuch der allgemeinen Pathologie, 111–117 (ed. Meesen, H.) 289–384 (Springer, Heidelberg, 1977).
Colantuoni, G., Hellums, J. D., Moake, J. L. & Alfrey, C. P. Trans. Am. Soc. artif. Internal Organs 23, 626–630 (1977).
Odegard, O Acta genet. (Basel) 17, 137–153 (1967).
Davidsen, O., Lindeneg, O. & Walsh, M. Acta med. scand. 205, 191–194 (1979).
Born, G. V. R. Lancet i 822, (1979).
Mackay, A. V. P., Healey, A. F. & Baker, J. Br. J. clin. Pharmac. 1, 425–430 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Born, G., Wehmeier, A. Inhibition of platelet thrombus formation by chlorpromazine acting to diminish haemolysis. Nature 282, 212–213 (1979). https://doi.org/10.1038/282212a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/282212a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.